|
MedPal AI PLC on Friday announced the launch of its artificial intelligence-driven retail pharmacy website, initially targeting the weight-loss market. The London-based digital health and AI company focused on wellness management said the MedPal.clinic platform is first targeting GLP-1 agonist treatments for weight loss, which it says present a ‘significant revenue opportunity’. MedPal said the platform combines ‘AI-powered triage with access to qualified independent prescribers and general practitioners’. MedPal.clinic is operated from a recently opened distribution centre at Ecotech business park, Swaffham. The company said the platform offers zero-cost consultations, multimodal access and same-day and next-day delivery for users. Chief Executive Jason Drummond said: ‘The launch of MedPal.clinic represents the culmination of our strategic vision to democratise healthcare access in the UK. By combining our proprietary AI triage system with advanced robotic dispensing at our Swaffham facility, we have created a platform that eliminates the financial barrier to GP and Independent Prescriber consultations entirely - something no other service has achieved. ‘Our multimodal approach, allowing patients to communicate via text, WhatsApp, or their preferred channel, sets a new standard for digital healthcare accessibility. Coupled with same-day delivery and 24/7 availability, MedPal.clinic addresses the fundamental failings of the traditional pharmacy model: cost, convenience, and accessibility.’ Shares in MedPal rose 5.2% to 7.10 pence on Friday afternoon in London. Copyright 2025 Alliance News Ltd. All Rights Reserved.
|
